Not checkedNot checked for notices yet.
Schwann cells modified to secrete MANF is a potential cellular therapy for peripheral nerve regeneration
Bhadrapriya Sivakumar, Caleb Hammond, Valeria Martinez and 4 more
Cell Regeneration · 2025
doi:10.1186/s13619-025-00247-9 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Effective therapies for peripheral nerve repair are still lacking despite active research in this field over the past years. The limited knowledge of biomolecules that equally promote axon regeneration and glial cell dynamics, which are critical for nerve regeneration, poses a major challenge in developing effective therapies. Here, we showed that the neurotrophic factor mesencephalic astrocyte-derived neurotrophic factor (MANF) equally promotes axon regeneration and glial cell dynamics favorable for nerve regeneration. Using adult rodent models, we showed that the endogenous expression of MANF is restricted to non-peptidergic sensory neurons. However, supplementation of exogenous MANF promoted the growth of all subtypes of adult sensory neurons. We also demonstrated that exogenous MANF promotes the proliferation and migration of adult primary Schwann Cells (SCs). Furthermore, we showed that local and repeated administration of MANF to injured nerves promotes axon regeneration in mice models. Finally, we devised a therapeutic approach by programming nerve-resident SCs to locally and continuously deliver MANF to injured nerves and showed that this approach improves axon regeneration. Overall, this work developed a therapeutic approach by harnessing the power of SCs as a local delivery system for MANF for nerve repair.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.